Literature DB >> 31195086

Comparative analysis of Rapid Equilibrium Dialysis (RED) and solid phase micro-extraction (SPME) methods for In Vitro-In Vivo extrapolation of environmental chemicals.

Kyle C Ferguson1, Yu-Syuan Luo1, Ivan Rusyn1, Weihsueh A Chiu2.   

Abstract

In vitro to in vivo extrapolation (IVIVE) is a critical component of the efforts to prioritize and assess environmental chemicals using high-throughput in vitro assays. The plasma unbound fraction (Fub) is a key toxicokinetic parameter in IVIVE, and is usually measured via the Rapid Equilibrium Dialysis (RED) assay widely used for pharmaceuticals. However, pharmaceuticals have a narrower range of physicochemical properties than environmental chemicals. Motivated by the observation that high LogKOW compounds appeared to have disproportionately low Fub measurements using RED, we added a protein-free control in order to verify equilibration to 100% unbound in the absence of proteins. We found that many high LogKOW non-pharmaceuticals fail to equilibrate in RED in protein-free controls, and thus had apparent values of Fub = 0 in plasma. In these cases, Solid Phase Microextraction (SPME) as an alternative method provided an accurate, though more time-consuming, alternative to accurately determine Fub. We propose an updated IVIVE workflow that adds a protein-free control to the RED protocol, with the use of alternative approaches, such as SPME, in cases where compounds fail to adequately equilibrate. These refinements will provide additional confidence in the use of IVIVE as part of high-throughput screening programs of chemicals.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Environmental chemicals; High-throughput screening; In vitro-in vivo extrapolation; Protein binding; Toxicokinetics

Mesh:

Substances:

Year:  2019        PMID: 31195086      PMCID: PMC6717004          DOI: 10.1016/j.tiv.2019.06.006

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  Prediction of hepatic drug clearance with a human microfluidic four-cell liver acinus microphysiology system.

Authors:  Courtney Sakolish; Yu-Syuan Luo; Alan Valdiviezo; Lawrence A Vernetti; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicology       Date:  2021-09-17       Impact factor: 4.221

Review 2.  IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.

Authors:  Xiaoqing Chang; Yu-Mei Tan; David G Allen; Shannon Bell; Paul C Brown; Lauren Browning; Patricia Ceger; Jeffery Gearhart; Pertti J Hakkinen; Shruti V Kabadi; Nicole C Kleinstreuer; Annie Lumen; Joanna Matheson; Alicia Paini; Heather A Pangburn; Elijah J Petersen; Emily N Reinke; Alexandre J S Ribeiro; Nisha Sipes; Lisa M Sweeney; John F Wambaugh; Ronald Wange; Barbara A Wetmore; Moiz Mumtaz
Journal:  Toxics       Date:  2022-05-01

3.  In Vitro Bioavailability of the Hydrocarbon Fractions of Dimethyl Sulfoxide Extracts of Petroleum Substances.

Authors:  Yu-Syuan Luo; Kyle C Ferguson; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

4.  Predictive Performance of Next Generation Physiologically Based Kinetic (PBK) Model Predictions in Rats Based on In Vitro and In Silico Input Data.

Authors:  Ans Punt; Jochem Louisse; Nicole Pinckaers; Eric Fabian; Bennard van Ravenzwaay
Journal:  Toxicol Sci       Date:  2022-02-28       Impact factor: 4.849

5.  The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression.

Authors:  Zhenghong Li; Carrie Sun; Sijia Tao; Adeboye O Osunkoya; Rebecca S Arnold; John A Petros; Xiongbing Zu; Carlos S Moreno
Journal:  Transl Oncol       Date:  2020-03-18       Impact factor: 4.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.